Patents by Inventor Richard Newmark

Richard Newmark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7867481
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: January 11, 2011
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • Publication number: 20100303815
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: May 28, 2010
    Publication date: December 2, 2010
    Applicant: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • Publication number: 20080124693
    Abstract: A system for determining an analyte (for example glucose) in a bodily fluid sample (e.g., a whole blood sample) includes a meter and at least one analytical test strip configured for the application of the bodily fluid sample thereon and for insertion into the meter for subsequent determination of the analyte. Furthermore, the meter includes a graphics-based step-by-step tutorial module with a user interface, a microprocessor unit and a memory unit storing a step-by-step tutorial that includes graphics-based images depicting use of the system. In addition, the user interface, microprocessor unit and memory unit are operatively linked and configured for sequential display of the graphics-based images of the step-by-step tutorial to the user via, for example, a display screen.
    Type: Application
    Filed: October 26, 2006
    Publication date: May 29, 2008
    Inventors: Mary McEvoy, Marcia Cheney, Tracy Newstadt, Richard Newmark
  • Publication number: 20080124692
    Abstract: A method for tutoring a user during use of a system for determining an analyte (for example, glucose) in a bodily fluid sample (e.g., a whole blood sample) include activating a system for determining an analyte in a bodily fluid sample. The system that is activated includes a meter and at least one analytical test strip configured for the application of the bodily fluid sample thereon and for insertion into the meter for subsequent determination of the analyte. Furthermore, the meter includes a graphics-based step-by-step tutorial module with a user interface, a microprocessor unit and a memory unit storing a step-by-step tutorial that includes graphics-based images depicting use of the system. In addition, the user interface, microprocessor unit and memory unit are operatively linked and configured for sequential display of the graphics-based images of the step-by-step tutorial to the user via, for example, a display screen.
    Type: Application
    Filed: October 26, 2006
    Publication date: May 29, 2008
    Inventors: Mary McEvoy, Marcia Cheney, Tracy Newstadt, Richard Newmark
  • Patent number: 7087224
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: August 8, 2006
    Assignee: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • Publication number: 20050106148
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 19, 2005
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco Coccia
  • Publication number: 20020077294
    Abstract: The invention relates to methods of treating a blood disorder in a mammmal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: October 2, 2001
    Publication date: June 20, 2002
    Applicant: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia